Apel Petra, Rousselle Christophe, Lange Rosa, Sissoko Fatoumata, Kolossa-Gehring Marike, Ougier Eva
German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
French Agency for Food, Environmental and Occupational Health & Safety (ANSES), France.
Int J Hyg Environ Health. 2020 Sep;230:113622. doi: 10.1016/j.ijheh.2020.113622. Epub 2020 Oct 9.
The European Joint Program "HBM4EU" is a joint effort of 30 countries and the European Environment Agency, co-funded under the European Commission's Horizon 2020 program, for advancing and implementing human biomonitoring (HBM) on a European scale and for providing scientific evidence for chemical policy making. One important outcome will be a Europe-wide improvement and harmonization of health risk assessment following the coordinated derivation or update of health-related guidance values referring to the internal body burden. These guidance values - named HBM guidance values or HBM-GVs - can directly be compared with HBM data. They are derived within HBM4EU for priority substances identified by the HBM4EU chemicals prioritization strategy based on existing needs to answer policy relevant questions as raised by national and EU policy makers. HBM-GVs refer to both the general population and occupationally exposed adults. Reports including the detailed reasoning for the values' proposals are subjected to a consultation process within all partner countries of the consortium to reach a broad scientific consensus on the derivation approach and on the derived values. The final HBM-GVs should be applied first within the HBM4EU project, but may also be useful for regulators and risk assessors outside this project. The subsequent adoption of derived HBM-GVs at EU-level needs to be discussed and decided within the responsible EU bodies. Nevertheless, the establishment of HBM-GVs as part of HBM4EU is already a step forward in strengthening HBM-based policy efforts for public and occupational health. The strategy for deriving HBM-GVs which is based on already existing approaches from the German HBM Commission, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) as well as from the US-based scientific consultant Summit Toxicology, the allocation of a level of confidence to the derived values, and the consultation process within the project are comprehensively described to enlighten the work accomplished under the HBM4EU initiative.
欧洲联合项目“人类生物监测促进健康与环境(HBM4EU)”是由30个国家和欧洲环境局共同开展的一项工作,由欧盟委员会的“地平线2020”计划共同资助,旨在在欧洲范围内推进和实施人类生物监测(HBM),并为化学品政策制定提供科学依据。一个重要成果将是在协调推导或更新与体内负荷相关的健康指导值之后,在全欧洲范围内改进和统一健康风险评估。这些指导值——称为HBM指导值或HBM-GVs——可直接与HBM数据进行比较。它们是在HBM4EU项目中针对HBM4EU化学品优先排序战略确定的优先物质推导得出的,该战略基于现有需求,以回答国家和欧盟政策制定者提出的与政策相关的问题。HBM-GVs适用于一般人群和职业暴露的成年人。包含这些值建议详细推理过程的报告将在该联盟所有伙伴国家内进行磋商,以便就推导方法和推导值达成广泛的科学共识。最终的HBM-GVs应首先在HBM4EU项目中应用,但对该项目之外的监管机构和风险评估人员也可能有用。在欧盟层面后续采用推导得出的HBM-GVs需要在负责的欧盟机构内部进行讨论和决定。尽管如此,将HBM-GVs作为HBM4EU的一部分加以确立,已然是在加强基于HBM的公共和职业健康政策方面向前迈出的一步。本文全面描述了基于德国HBM委员会、法国食品、环境与职业健康安全局(ANSES)以及美国科学顾问Summit Toxicology现有方法推导HBM-GVs的策略、为推导值分配置信水平以及项目内部的磋商过程,以阐明在HBM4EU倡议下所完成的工作。